Page last updated: 2024-08-26

olivacine and Leukemia L 1210

olivacine has been researched along with Leukemia L 1210 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, S; el-Hamouly, W; Modi, SP; Portuese, E; Ruckdeschel, JC1
Carrez, D; Croisy, A; Jaroszewicz, I; Jasztold-Howorko, R; Nasulewicz, A; Opolski, A; Pełczyńska, M1
Atassi, G; Bisagni, E; Guilbaud, N; Jasztold-Howorko, R; Kraus-Berthier, L; Landras, C; Léonce, S; Pierré, A; Prost, JF; Rolland, Y1

Other Studies

3 other study(ies) available for olivacine and Leukemia L 1210

ArticleYear
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
    Journal of medicinal chemistry, 1992, Dec-25, Volume: 35, Issue:26

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship; Tumor Cells, Cultured

1992
Synthesis, structure, and cytostatic properties of new olivacine derivatives.
    Archiv der Pharmazie, 2004, Volume: 337, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cells, Cultured; Drug Screening Assays, Antitumor; Ellipticines; Humans; Indicators and Reagents; Leukemia L1210; Mice

2004
Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives.
    Journal of medicinal chemistry, 1994, Jul-22, Volume: 37, Issue:15

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Survival; Colonic Neoplasms; Ellipticines; Leukemia L1210; Mice; Neoplasm Transplantation; Tumor Cells, Cultured

1994